The JAMA Network published an Orginal Investigation on January 18, 2022 that found that U.S. Preventive Services Task Force guideline-concordant cervical cancer screening rates decreased between 2005 and 2019, before the COVID-19 pandemic.
The most common reason for not receiving cervical cancer screening was 'not knowing cancer screening was needed.'
Among women in the older age cohort, those responding they 'did not' receive screening was because they did not have a recommendation from healthcare practitioners more than doubled in 2019, from 5.5% to 12%.
In this cross-sectional study of 20,557 women eligible for cervical cancer screening in the U.S., the proportion of women without up-to-date screening significantly increased from 14.4% in 2005 to 23.0% in 2019 among all sociodemographic groups.
The study's findings also revealed that barriers to screening significantly varied by sociodemographic factors, suggesting cultural adaptation of interventions will be an essential factor in the success of efforts to increase cervical cancer screening uptake.
Along with increasing HPV vaccine coverage, improving cervical cancer screening rates represents an essential strategy for national campaigns to eliminate cervical cancer as a public health concern.
Campaigns addressing patient knowledge and practitioner communication may help to improve cervical cancer screening rates, and cultural adaptation of interventions is needed to reduce existing disparities.
Corresponding Author: Ryan Suk, Ph.D., MS, Department of Management, Policy, and Community Health, University of Texas Health Science Center at Houston School of Public Health ([email protected]). No industry conflicts of interest were disclosed.